CCA
TVGNW icon

Castle Creek Arbitrage’s Tevogen Bio Warrant TVGNW Stock Holding History

Castle Creek Arbitrage’s Portfolio TVGNW Stock Details TVGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-196,900
Closed -$9.49K – 70
2023
Q3 		$9.49K Sell
196,900
-3,100
-2% -$166 ﹤0.01% 185
2023
Q2 		$8.26K Hold
200,000
– – ﹤0.01% 292
2023
Q1 		$16K Hold
200,000
– – ﹤0.01% 308
2022
Q4 		$1.3K Buy
+200,000
New +$5.82K ﹤0.01% 500

Other funds holding TVGNW

FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return

Castle Creek Arbitrage's TVGNW Position: Q4 2023 in Review

Castle Creek Arbitrage sold out of Tevogen Bio Warrant (TVGNW) in Q4 2023, closing a stake of 196,900 shares — an estimated $9.49K sold.

Castle Creek Arbitrage first reported a position in TVGNW in Q4 2022 and held it in 4 quarters. The position peaked at $16K in Q1 2023. 48 funds tracked by Wall St. Rank hold TVGNW as of Q4 2023.

  • Castle Creek Arbitrage reported no remaining Tevogen Bio Warrant position as of Q4 2023 after selling out during the quarter.
  • Castle Creek Arbitrage sold 196,900 Tevogen Bio Warrant shares in Q4 2023, an estimated $9.49K.
  • Castle Creek Arbitrage first reported a position in Tevogen Bio Warrant in Q4 2022 and held it in 4 quarters.
  • Castle Creek Arbitrage's Tevogen Bio Warrant position peaked at $16K in Q1 2023.
  • 48 funds tracked by Wall St. Rank held Tevogen Bio Warrant as of Q4 2023.

Based on Castle Creek Arbitrage's 13F filing for Q4 2023.